UAB "Optifarma"
Company details
Legal status
ActiveCompany ID
VAT code
Incorporation date
28/07/2003Company's manager/representative
Share capital
2,896.00 EURActivity
Wholesale of pharmaceutical goodsContacts
Company registration address

B
HighReliability

Fair Business loans
Borrow for business up to 50 000 € without collateralNumber of employees
2* during past year
Average wage
No data available* during past year
Debts
0.00 €* during past year
Turnover
679,473 €Credit report
25
Data sourcesBusiness linkages
1
LinkageMonitoring
10
Changes during the yearSimilar companies
3014
Similar companiesCompany's value
Register and
explore Okredo dataCredit limit
Estimated
UAB "Optifarma" financial ratios
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
1,617,046 |
691,045 |
154,899 |
133,844 |
57,198 |
21.95 |
8.28 |
733,979 |
605,989 |
26,468 |
1,313,287 |
2023 |
---|
890,446 |
445,223 |
30,358 |
25,776 |
12,888 |
14.08 |
2.89 |
759,755 |
448,989 |
20,102 |
1,190,243 |
2024 |
---|
679,473 |
339,737 |
28,798 |
24,093 |
12,047 |
22.74 |
3.55 |
783,847 |
480,320 |
29,230 |
1,234,011 |
Register and
explore Okredo data2024 |
---|
679,473 |
339,737 |
28,798 |
24,093 |
12,047 |
22.74 |
3.55 |
783,847 |
480,320 |
29,230 |
1,234,011 |
Register and
explore Okredo data2024
Turnover (€)
679,473 €-24 % *
Sales per employee (€)
339,737 €-24 % *
Profit before tax (€)
28,798 €-5 % *
Net Profit (€)
24,093 €-7 % *
Profit per employee (€)
12,047 €-7 % *
Total profitability (%)
22.74 %61.51 % *
Net profitability (%)
3.55 %22.84 % *
Equity (€)
783,847 €3 % *
Amounts Payable And Liabilities (€)
480,320 €7 % *
Non-current Assets (€)
29,230 €45 % *
CurrentAssets (€)
1,234,011 €4 % *
Credit history
No. of unpaid debts
Register and
explore Okredo dataAmount of unpaid debts
Register and
explore Okredo dataCredit report
Premium users: 1.00 credit
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
Creditor/Data source | Debt amount | Debt date | Debt type |
---|---|---|---|
- | - | - | - |
Creditor/Data source | Debt amount | Debt date / Payment date | Debt type |
---|---|---|---|
- | - | - | - |
Courts
Defendant
(0)
Plaintiff
(0)
3rd party
(0)
Case No./date | Process parties | Case/Court ruling | Court | No. of court hearings | More |
---|---|---|---|---|---|
- | - | - | - | - | - |
Case No./date | Process parties | Case/Court ruling | Court | No. of court hearings | More |
---|---|---|---|---|---|
- | - | - | - | - | - |
Case No./date | Process parties | Case/Court ruling | Court | No. of court hearings | More |
---|---|---|---|---|---|
- | - | - | - | - | - |
ESG data
Energy performance of the company's head office building
Energy efficiency
Vehicles
Company's eco score according CO² of vehicle fleet
Maximum environmental friendliness
Lowest environmental friendliness
Vehicles
CLASS
AMOUNT
Total
1
Eco score | Brand, model | Category | Engine capacity | Fuel |
---|---|---|---|---|
TOYOTA TOYOTA RAV4First registration: 13/04/2021 | Passenger car | 2,487.00 cm³ | Petrol / Electricity |
Trademarks
Company registered trademarks
Trademark view | Trademark | Type | Application No | Registration No | Expire | TM status |
---|---|---|---|---|---|---|
SVEIKA KRYPTIS | Graphical | 2024 1302 | 92208 | 18/06/2034 | Registered | |
Optifarma | Graphical | 2004 1841 | 51979 | 16/09/2014 | De-registered without renewal | |
SAKURA medica | Graphical | 2004 1840 | 51978 | 16/09/2014 | De-registered without renewal |
Public data
Govermental support
Institution | Support measure |
---|---|
![]() | ILTE business promotion measures (guarantees provided) in 2022 |
![]() | ILTE business promotion measures (guarantees provided) in 2021 |
![]() | ILTE business promotion measures (subsidies, compensations) in 2021 |
![]() | ILTE business promotion measures (guarantees provided) in 2021 |
![]() | Covid 19 aid measures (subsidies, compensation) in 2020 - 2022 |
Register and
explore Okredo dataPublic negative information
Data source | Information |
---|---|
![]() | Tax inspectorate information on payments in cash |
![]() | Public procurement office information on unreliable suppliers |
![]() | Public procurement office information on those that supplied false data |
![]() | Public procurement office information on possible disqualification from public procurement procedures |
![]() | Redundancy of employees group (number of employees notified, date of announcement) |
Register and
explore Okredo dataPublic data
Data source | Information |
---|---|
![]() | Data from the B2Lithuania database of exporters |
![]() | The biggest taxpayers in 2021 |
![]() | Top taxpayers in 2021 excluding excise duties and VAT. |
![]() | Top personal income tax payers in 2021 |
![]() | Top taxpayers for corporate income tax in 2021 |
Register and
explore Okredo dataLicenses
Licences, certificates, permits, other licensing documents
Registration number | Term of validity | Licensing authority | Type | Species |
---|---|---|---|---|
1284 2021-09-08 | 2021-09-08 | Valstybinė maisto ir veterinarijos tarnyba | Identification | Food handling entity approval certificate |
130019863 2021-09-08 | 2021-09-08 | Valstybinė maisto ir veterinarijos tarnyba | Registration | Food handling entity registration |
511 2008-05-26 | 2008-05-26 - 2022-05-12 | Valstybinė maisto ir veterinarijos tarnyba | Identification | Food handling entity approval certificate |
130004180 2008-05-26 | 2008-05-26 | Valstybinė maisto ir veterinarijos tarnyba | Registration | Food handling entity registration |
Public procurement
No. of won tenders
0* during past yearTotal value of contracts
0 €Number of announced tenders
0* during past yearTotal value of contracts
0 €Date | Procurer/contractor | Amount | Project |
---|---|---|---|
05/09/2024 | Uždaroji akcinė bendrovė 'Vilniaus apšvietimas' | 581 € | Greitieji SARS-Cov-2 antigeno testai |
11/01/2024 | Uždaroji akcinė bendrovė "LITESKO" | 835 € | SARS-COV-2 ANTIGENŲ GREITŲJŲ TESTŲ PIRKIMAS |
13/11/2023 | Uždaroji akcinė bendrovė 'Vilniaus apšvietimas' | 399 € | Greitieji SARS-Cov-2 antigeno testai |
30/11/2022 | Uždaroji akcinė bendrovė "LITESKO" | 690 € | SARS-COV-2 ANTIGENŲ GREITŲJŲ TESTŲ PIRKIMAS |
10/10/2022 | Uždaroji akcinė bendrovė "LITESKO" | 1,809 € | SARS-CoV-2 antigeno greitieji testai |
Date | Procurer/contractor | Amount | Project |
---|---|---|---|
- | - | - | - |
Archive of articles
Similar companies
Category:
Wholesale of pharmaceutical goodsComp. code:
126237331Reg. date:
03/06/2003Turnover:
200-500 k €No. of employees:
1Category:
Wholesale of pharmaceutical goodsComp. code:
135926717Reg. date:
12/09/2002Turnover:
0,5-1 M €No. of employees:
5Category:
Wholesale of pharmaceutical goodsComp. code:
300037749Reg. date:
01/07/2004Turnover:
200-500 k €No. of employees:
3Category:
Wholesale of pharmaceutical goodsComp. code:
135483969Reg. date:
11/06/1999Turnover:
0,5-1 M €No. of employees:
1Category:
Wholesale of pharmaceutical goodsComp. code:
111740615Reg. date:
29/06/2001Turnover:
0,5-1 M €No. of employees:
1Description
About UAB "Optifarma"
UAB "Optifarma" was established in 28/07/2003, its legal status according to data of Registry of Legal Entities is Active.Main activity of the company according NACE2 classification – Wholesale of pharmaceutical goods, 46.46.00. Company is owned by 1 shareholder. Company's representation right – Sole representation.
In 2024 UAB "Optifarma" turnover was 679,473 EUR, gross profit 24,093 EUR. According to SODRA company has 2 employees. UAB "Optifarma" is registered at – Vilnius, Gedvydžių g. 24-2, LT-06308.
Business objectives of the company as officially recorded in the Register of Legal Entities: Bendrovės veiklos tikslai: prekyba, gamyba, paslaugos.
Bendrovė gali užsiimti bet kokia kita veikla, kuri neprieštarauja Lietuvos Respublikos teisės aktams. (no translation available)
All data about UAB "Optifarma" is up to date and consistent with the primary data source.